APA

Tobinai K., Watanabe T., Tanimoto K., Maruyama D., Nakata M., Itoh K., Morishima Y., Ogura M., Usui N., Kasai M., Terauchi T., Nawano S., Matsusako M., Matsuno Y., Nakamura S., Mori S. & Ohashi Y. (20090909). Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. : Cancer science.

Chicago

Tobinai Kensei, Watanabe Takashi, Tanimoto Kazuki, Maruyama Dai, Nakata Masanobu, Itoh Kuniaki, Morishima Yasuo, Ogura Michinori, Usui Noriko, Kasai Masaharu, Terauchi Takashi, Nawano Shigeru, Matsusako Masaki, Matsuno Yoshihiro, Nakamura Shigeo, Mori Shigeo and Ohashi Yasuo. 20090909. Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. : Cancer science.

Harvard

Tobinai K., Watanabe T., Tanimoto K., Maruyama D., Nakata M., Itoh K., Morishima Y., Ogura M., Usui N., Kasai M., Terauchi T., Nawano S., Matsusako M., Matsuno Y., Nakamura S., Mori S. and Ohashi Y. (20090909). Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. : Cancer science.

MLA

Tobinai Kensei, Watanabe Takashi, Tanimoto Kazuki, Maruyama Dai, Nakata Masanobu, Itoh Kuniaki, Morishima Yasuo, Ogura Michinori, Usui Noriko, Kasai Masaharu, Terauchi Takashi, Nawano Shigeru, Matsusako Masaki, Matsuno Yoshihiro, Nakamura Shigeo, Mori Shigeo and Ohashi Yasuo. Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. : Cancer science. 20090909.